Following earlier announcements on RB Investment LLC’s entry into the Gulf healthcare sector, Dr. Ruchit Bhatnagar has confirmed that the group’s diagnostics and interventional therapy initiative is now progressing into a structured development and partnership phase. The project, centred on modern diagnostics, laboratory services and targeted therapeutic support, is being shaped to serve patients across Oman, the UAE and Qatar, with additional GCC locations expected in later stages.
Over the past several months, RB Investment LLC has been engaged in detailed discussions with established diagnostic chains, hospital groups and medical technology providers in the region. These partnerships are intended to strengthen operational capacity and ensure clinical standards that match the region’s expectations for accuracy, reliability and efficiency. The model integrates advanced diagnostics with selective interventional therapy options, creating a hybrid framework suited to the evolving healthcare needs of the Gulf.
Ms. Bhawna Bhatt has been closely involved in this expansion, contributing significantly to operational planning, patient workflow design and the development of institutional partnerships. Her experience in healthcare coordination and service delivery adds depth to the project, particularly in areas of patient experience, quality oversight and structured collaboration with regional medical institutions.
Building a modern diagnostics and therapy ecosystem
The concept being developed under RB Investment LLC seeks to address critical areas where regional demand continues to grow, including:
• faster and more dependable diagnostic pathways
• integrated lab networks connected to hospitals and specialty centres
• accessible interventional therapy support
• digitally enabled reporting, logistics and workflow systems
• patient centric infrastructure matching GCC service standards
By combining diagnostics with appropriate interventional support, the initiative is positioned to serve both preventive and specialised care requirements. Several potential tie-ups with existing diagnostic chains are under evaluation, enabling accelerated deployment and scalable expansion across key Gulf cities.
Speaking about the ongoing development, Dr. Ruchit Bhatnagar said,
“Diagnostics and interventional care form the foundation of modern healthcare. Our goal is to build a high quality, comprehensive solution that works closely with established medical institutions in the Gulf. The progress so far has been encouraging and the partnerships we are building will help us deliver care that is efficient, reliable and aligned with the expectations of the region.”
Healthcare analysts note that GCC countries continue to invest heavily in medical infrastructure, driven by population growth, lifestyle shifts and a rising emphasis on early detection and specialised care. RB Investment LLC’s model aims to align with and reinforce these priorities.
A structured roadmap for rollout
The next phase will include detailed operational planning for the first units in Oman and the UAE, along with technology integration, laboratory logistics and tele-reporting support. RB Investment LLC intends to establish a long term presence across the region through a mix of new centre development and collaborations with existing diagnostic networks.
With Ms. Bhawna Bhatt’s involvement and Dr. Bhatnagar’s leadership, the initiative is entering a significant stage of execution and is positioned to move toward launch in the coming months.
About RB Investment LLC
RB Investment LLC is an investment and development firm focused on long term opportunities across healthcare, real estate, technology, logistics and consumer sectors in the Gulf and Asia. The company invests in high potential sectors where strategic partnerships and disciplined execution can create sustainable value.
